N.J. Admin. Code § 8:111-20.1

Current through Register Vol. 56, No. 12, June 17, 2024

Section 8:111-20.1 - Infection prevention and control

(a) The administrator shall ensure the development and implementation of an infection prevention and control program.

(b) The residential substance use disorders treatment facility shall establish an infection control committee composed at least of the medical director, a representative of administration and a representative from nursing services and a person with a health care background designated by the administrator to be responsible for implementing the policies and procedures regarding infection prevention and control in the facility.

(c) The infection control committee, in consultation with each service in the facility, shall develop, implement, and annually review and revise as necessary written policies and procedures regarding infection prevention and control, addressing at least the following:

1. The system within the facility for investigating, reporting, and evaluating the occurrence of all infections or diseases which are reportable in accordance with N.J.A.C. 8:57, Communicable Diseases, or are conditions that may be related to activities and procedures of the facility;

2. The system within the facility for identifying and monitoring nosocomial and other infections in accordance with the latest CDC infection control guidelines incorporated herein by reference, and available from the CDC Division of Healthcare Quality Promotion website, "Infection Control in Healthcare Settings," at http://www.cdc.gov/hai; or toll free 1-800-311-3435; in particular, the "Guideline for Prevent Healthcare-Associated Pneumonia (2003)" accessible at http://www.cdc.gov/hicpac/pubs.html and the "Guidelines for Hand Hygiene in Healthcare Settings" (2002), accessible at http://www.cdc.gov/hicpac/pubs.html, incorporated herein by reference, as amended and supplemented;

3. The facility's infection and control practices shall be in compliance with the CDC infection control guidelines at (c)2 above, and with the Occupational Safety and Health Administration (OSHA) rules at 29 CFR 1910.1030, Bloodborne Pathogens, incorporated herein by reference, available from the OSHA website, www.osha.gov;

4. The control measures or studies to be initiated by the facility following identification of an infection control problem;

5. The facility's aseptic techniques, procedures to ensure employee health in accordance with 10:161A-3.7 and staff training;

6. Care of clients with communicable diseases;

7. Exclusion of personnel with communicable diseases from work and authorization to return to work;

8. The facility's surveillance techniques to minimize sources and transmission of infection;

9. The facility's disinfection and cleaning practices and techniques, including:

i. Care of instruments, solutions, dressings, articles and surfaces; and

ii. Section, storage use and disposal of single use and other client care items;

10. The facility's practices regarding collection, handling, storage, decontamination, disinfection, sterilization and disposal of regulated medical waste and all other solid and liquid waste; and

11. The facility shall not reuse single use client care items and shall reprocess and reuse other client care items in accordance with manufacturers' recommendations.

N.J. Admin. Code § 8:111-20.1

Amended and recodified from 10:161A-20.1 53 N.J.R. 2208(a), effective 12/20/2021